Illuminating the Regenerative Properties of Stem Cells In Vivo with Bioluminescence Imaging
- PMID: 33089922
- DOI: 10.1002/biot.202000248
Illuminating the Regenerative Properties of Stem Cells In Vivo with Bioluminescence Imaging
Abstract
Preclinical animal studies are essential to the development of safe and effective stem cell therapies. Bioluminescence imaging (BLI) is a powerful tool in animal studies that enables the real-time longitudinal monitoring of stem cells in vivo to elucidate their regenerative properties. This review describes the application of BLI in preclinical stem cell research to address critical challenges in producing successful stem cell therapeutics. These challenges include stem cell survival, proliferation, homing, stress response, and differentiation. The applications presented here utilize bioluminescence to investigate a variety of stem and progenitor cells in several different in vivo models of disease and implantation. An overview of luciferase reporters is provided, along with the advantages and disadvantages of BLI. Additionally, BLI is compared to other preclinical imaging modalities and potential future applications of this technology are discussed in emerging areas of stem cell research.
Keywords: cellular therapy; imaging; medical biotechnology; regenerative medicine; stem cells.
© 2020 The Authors. Biotechnology Journal published by Wiley-VCH GmbH.
Similar articles
-
Evaluating reporter genes of different luciferases for optimized in vivo bioluminescence imaging of transplanted neural stem cells in the brain.Contrast Media Mol Imaging. 2013 Nov-Dec;8(6):505-13. doi: 10.1002/cmmi.1549. Contrast Media Mol Imaging. 2013. PMID: 24375906
-
The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction.Theranostics. 2018 Apr 14;8(10):2799-2813. doi: 10.7150/thno.22980. eCollection 2018. Theranostics. 2018. PMID: 29774076 Free PMC article.
-
Using Bioengineered Bioluminescence to Track Stem Cell Transplantation In Vivo.Methods Mol Biol. 2020;2126:1-11. doi: 10.1007/978-1-0716-0364-2_1. Methods Mol Biol. 2020. PMID: 32112374 Free PMC article.
-
In vivo bioluminescence for tracking cell fate and function.Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H663-71. doi: 10.1152/ajpheart.00337.2011. Epub 2011 Jun 10. Am J Physiol Heart Circ Physiol. 2011. PMID: 21666118 Free PMC article. Review.
-
In Vivo Molecular Bioluminescence Imaging: New Tools and Applications.Trends Biotechnol. 2017 Jul;35(7):640-652. doi: 10.1016/j.tibtech.2017.03.012. Epub 2017 May 10. Trends Biotechnol. 2017. PMID: 28501458 Review.
Cited by
-
In Vivo Tumorigenicity of the 20q11.21 Amplicon in an Engraftment Model of hPSCs and Differentiated Liver Cells.J Stem Cells Regen Med. 2023 Apr 30;19(1):3-13. doi: 10.46582/jsrm.1901002. eCollection 2023. J Stem Cells Regen Med. 2023. PMID: 37366409 Free PMC article.
-
Noninvasive DWI tracking of hiPSCs differentiation into RTECs in AKI recovery via the KSP promoter-mediated AQP1 strategy.Theranostics. 2025 Apr 9;15(11):5106-5120. doi: 10.7150/thno.109826. eCollection 2025. Theranostics. 2025. PMID: 40303334 Free PMC article.
References
-
- H. M. Blau, G. Q. Daley, N. Engl. J. Med. 2019, 380, 1748.
-
- A. Trounson, C. McDonald, Cell Stem Cell 2015, 17, 11.
-
- C. M. Madl, S. C. Heilshorn, H. M. Blau, Nature 2018, 557, 335.
-
- J. Frey-Vasconcells, K. J. Whittlesey, E. Baum, E. G. Feigal, Stem Cells Transl. Med. 2012, 1, 353.
-
- E. Gu, W.-Y. Chen, J. Gu, P. Burridge, J. C. Wu, Theranostics 2012, 2, 335.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources